These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16394250)

  • 1. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.
    Hall JM; McDonnell DP
    Mol Interv; 2005 Dec; 5(6):343-57. PubMed ID: 16394250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptors: therapies targeted to receptor subtypes.
    Nilsson S; Gustafsson JÅ
    Clin Pharmacol Ther; 2011 Jan; 89(1):44-55. PubMed ID: 21124311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological role of estrogen receptors alpha and beta in cancer.
    Pearce ST; Jordan VC
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):3-22. PubMed ID: 15094156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen signaling: a subtle balance between ER alpha and ER beta.
    Matthews J; Gustafsson JA
    Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.
    Girault I; Bièche I; Lidereau R
    Maturitas; 2006 Jul; 54(4):342-51. PubMed ID: 16822624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M; Ni J; Chang HC; Lin CY; Muyan M; Yeh S
    Carcinogenesis; 2009 May; 30(5):841-50. PubMed ID: 19126643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of estrogen receptor beta in breast cancer.
    Saji S; Hirose M; Toi M
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():21-6. PubMed ID: 16273360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.
    den Hollander P; Rayala SK; Coverley D; Kumar R
    Cancer Res; 2006 Nov; 66(22):11021-9. PubMed ID: 17108141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.
    Cheng AS; Jin VX; Fan M; Smith LT; Liyanarachchi S; Yan PS; Leu YW; Chan MW; Plass C; Nephew KP; Davuluri RV; Huang TH
    Mol Cell; 2006 Feb; 21(3):393-404. PubMed ID: 16455494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationship of estrogen receptor alpha and beta: impact on human health.
    Ascenzi P; Bocedi A; Marino M
    Mol Aspects Med; 2006 Aug; 27(4):299-402. PubMed ID: 16914190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling by estrogens.
    Cheskis BJ; Greger JG; Nagpal S; Freedman LP
    J Cell Physiol; 2007 Dec; 213(3):610-7. PubMed ID: 17886255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
    J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
    Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
    J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.